Pasar al contenido principal

EVALUACION GENETICA DE LA CARDIOTOXICIDAD INDUCIDA POR QUIMIOTERAPIA: ESTUDIO DE ASOCIACION DE GENOMA COMPLETO Y SECUENCIACION DE EXOMA DE INDIVIDUOS CON FENOTIPO MAS SEVERO

PI19/01283

•
Nombre agencia financiadora Instituto de Salud Carlos III
Acrónimo agencia financiadora ISCIII
Programa Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de Investigación en Salud
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION INSTITUTO DE INVESTIGACION SANITARIA DE SANTIAGO DE COMPOSTELA
Centro realización INSTITUTO DE INVESTIGACION SANITARIA DE SANTIAGO DE COMPOSTELA (IDIS)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 5
Encontrada(s) 1 página(s)

RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Molecular autopsy: Twenty years of post-mortem diagnosis in sudden cardiac death

  • Martínez Barrios, Estefanía
  • Grassi, Simone
  • Brión, María
  • Toro Cebada, Rocío
  • Cesar, Sergi
  • Cruzalegui, José
  • Coll, Mònica
  • Alcalde, Mireia
  • Brugada, Ramón
  • Greco, Andrea
  • Ortega Sánchez, María Luisa
  • Barberia, Eneko
  • Oliva, Antonio
  • Sarquella-Brugada, Georgia
  • Campuzano, Oscar
In the forensic medicine field, molecular autopsy is the post-mortem genetic analysis performed to attempt to unravel the cause of decease in cases remaining unexplained after a comprehensive forensic autopsy. This negative autopsy, classified as negative or non-conclusive, usually occurs in young population. In these cases, in which the cause of death is unascertained after a thorough autopsy, an underlying inherited arrhythmogenic syndrome is the main suspected cause of death. Next-generation sequencing allows a rapid and cost-effectives genetic analysis, identifying a rare variant classified as potentially pathogenic in up to 25% of sudden death cases in young population. The first symptom of an inherited arrhythmogenic disease may be a malignant arrhythmia, and even sudden death. Early identification of a pathogenic genetic alteration associated with an inherited arrhythmogenic syndrome may help to adopt preventive personalized measures to reduce risk of malignant arrhythmias and sudden death in the victim’s relatives, at risk despite being asymptomatic. The current main challenge is a proper genetic interpretation of variants identified and useful clinical translation. The implications of this personalized translational medicine are multifaceted, requiring the dedication of a specialized team, including forensic scientists, pathologists, cardiologists, pediatric cardiologists, and geneticists., 12 páginas
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Molecular autopsy, Twenty years of post-mortem diagnosis in sudden cardiac death

  • Martínez-Barrios, Estefanía|||0000-0002-5856-1906
  • Grassi, Simone
  • Brión, María
  • Toro, Rocío
  • Cesar, Sergi|||0000-0002-2798-1756
  • Cruzalegui, José|||0000-0003-2382-0979
  • Coll, Mònica|||0000-0003-1214-803X
  • Alcalde, Mireia|||0000-0002-7222-0913
  • Brugada, Ramon|||0000-0001-6607-3032
  • Greco, Andrea
  • Ortega-Sánchez, Marisa|||0000-0003-0764-1452
  • Barberia, Eneko|||0000-0001-5804-3597
  • Oliva, Antonio
  • Sarquella-Brugada, Georgia|||0000-0002-6857-8904
  • Campuzano, Óscar|||0000-0001-5298-5276
In the forensic medicine field, molecular autopsy is the post-mortem genetic analysis performed to attempt to unravel the cause of decease in cases remaining unexplained after a comprehensive forensic autopsy. This negative autopsy, classified as negative or non-conclusive, usually occurs in young population. In these cases, in which the cause of death is unascertained after a thorough autopsy, an underlying inherited arrhythmogenic syndrome is the main suspected cause of death. Next-generation sequencing allows a rapid and cost-effectives genetic analysis, identifying a rare variant classified as potentially pathogenic in up to 25% of sudden death cases in young population. The first symptom of an inherited arrhythmogenic disease may be a malignant arrhythmia, and even sudden death. Early identification of a pathogenic genetic alteration associated with an inherited arrhythmogenic syndrome may help to adopt preventive personalized measures to reduce risk of malignant arrhythmias and sudden death in the victim's relatives, at risk despite being asymptomatic. The current main challenge is a proper genetic interpretation of variants identified and useful clinical translation. The implications of this personalized translational medicine are multifaceted, requiring the dedication of a specialized team, including forensic scientists, pathologists, cardiologists, pediatric cardiologists, and geneticists.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non-ischaemic dilated cardiomyopathy

  • Mirelis, Jesús G.|||0000-0002-3083-8627
  • Escobar-Lopez, Luis|||0000-0002-4354-7263
  • Ochoa, Juan Pablo|||0000-0002-7966-0313
  • Espinosa, Maria Angeles
  • Villacorta, Eduardo|||0000-0003-0486-1740
  • Navarro Peñalver, Marina|||0000-0002-6254-6039
  • Casas, Guillem|||0000-0001-7122-320X
  • Mora-Ayestarán, Nerea|||0000-0002-2127-5287
  • Barriales-Villa, Roberto|||0000-0002-6721-3487
  • Mogollón-Jiménez, María Victoria
  • García Pinilla, José Manuel|||0000-0001-5999-5741
  • García-Granja, Pablo Elpidio|||0000-0002-0750-1567
  • Climent, Vicente|||0000-0001-7362-1922
  • Palomino-Doza, Julian
  • García-Álvarez, Ana|||0000-0002-1718-2424
  • Alvarez Barredo, María|||0000-0002-8545-8138
  • Cabrera-Borrego, Eva|||0000-0003-2997-2391
  • Ripoll-Vera, Tomás|||0000-0001-9222-325X
  • Peña-Peña, María Luisa
  • Rodríguez-González, Elena
  • Gallego-Delgado, María|||0000-0003-0726-9646
  • Gonzalez-Carrillo, Josefa
  • Fernández-Ávila, Ana
  • Rodríguez Palomares, José F.|||0000-0002-7229-9780
  • Brugada, Ramon|||0000-0001-6607-3032
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Dominguez, Fernando
  • García-Pavía, Pablo|||0000-0002-5470-2257
Genotype and left ventricular scar on cardiac magnetic resonance (CMR) are increasingly recognized as risk markers for adverse outcomes in non-ischaemic dilated cardiomyopathy (DCM). We investigated the combined influence of genotype and late gadolinium enhancement (LGE) in assessing prognosis in a large cohort of patients with DCM. Outcomes of 600 patients with DCM (53.3 ± 14.1 years, 66% male) who underwent clinical CMR and genetic testing were retrospectively analysed. The primary endpoints were end-stage heart failure (ESHF) and malignant ventricular arrhythmias (MVA). During a median follow-up of 2.7 years (interquartile range 1.3-4.9), 24 (4.00%) and 48 (8.00%) patients had ESHF and MVA, respectively. In total, 242 (40.3%) patients had pathogenic/likely pathogenic variants (positive genotype) and 151 (25.2%) had LGE. In survival analysis, positive LGE was associated with MVA and ESHF (both, p < 0.001) while positive genotype was associated with ESHF (p = 0.034) but not with MVA (p = 0.102). Classification of patients according to genotype (G+/G-) and LGE presence (L+/L-) revealed progressively increasing events across L-/G-, L-/G+, L+/G- and L+/G+ groups and resulted in optimized MVA and ESHF prediction (p < 0.001 and p = 0.001, respectively). Hazard ratios for MVA and ESHF in patients with either L+ or G+ compared with those with L-/G- were 4.71 (95% confidence interval: 2.11-10.50, p < 0.001) and 7.92 (95% confidence interval: 1.86-33.78, p < 0.001), respectively. Classification of patients with DCM according to genotype and LGE improves MVA and ESHF prediction. Scar assessment with CMR and genotyping should be considered to select patients for primary prevention implantable cardioverter-defibrillator placement. Non-ischaemic dilated cardiomyopathy (NI DCM) patients with positive genotype and/or late gadolinium enhancement (LGE) show increased risk of ventricular arrhythmias and end-stage heart failure (ESHF) during follow-up. CI, confidence interval; HR, hazard ratio; LVEF, left ventricular ejection fraction; MVA, malignant ventricular arrhythmia.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Clinical Risk Score to Predict Pathogenic Genotypes in Patients With Dilated Cardiomyopathy

  • Escobar-Lopez, Luis|||0000-0002-4354-7263
  • Ochoa, Juan Pablo|||0000-0002-7966-0313
  • Royuela, Ana
  • Verdonschot, Job A.J.
  • Ferro, Matteo Dal
  • Espinosa, Maria Angeles
  • Sabater-Molina, Maria
  • Gallego-Delgado, María|||0000-0003-0726-9646
  • Larrañaga-Moreira, Jose M.
  • García Pinilla, José Manuel|||0000-0001-5999-5741
  • Basurte-Elorz, María Teresa|||0000-0002-8689-0301
  • Rodríguez Palomares, José F.|||0000-0002-7229-9780
  • Climent, Vicente|||0000-0001-7362-1922
  • Bermudez Jimenez, Francisco J.|||0000-0003-0325-7349
  • Mogollón-Jiménez, María Victoria
  • Lopez, Javier
  • Peña-Peña, Maria Luisa
  • García-Álvarez, Ana|||0000-0002-1718-2424
  • López-Abel, Bernardo
  • Ripoll-Vera, Tomás|||0000-0001-9222-325X
  • Palomino-Doza, Julian
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Brugada, Ramon|||0000-0001-6607-3032
  • Idiazabal, Uxua
  • Mirelis, Jesus G.
  • Dominguez, Fernando
  • Henkens, Michiel T.H.M.
  • Krapels, Ingrid P.C.
  • Brunner, Han G.
  • Paldino, Alessia
  • Zaffalon, Denise
  • Mestroni, Luisa
  • Sinagra, Gianfranco|||0000-0003-2700-8478
  • Heymans, Stephane R.B.
  • Merlo, Marco|||0000-0002-1022-3131
  • García-Pavia, Pablo
Although genotyping allows family screening and influences risk-stratification in patients with nonischemic dilated cardiomyopathy (DCM) or isolated left ventricular systolic dysfunction (LVSD), its result is negative in a significant number of patients, limiting its widespread adoption. This study sought to develop and externally validate a score that predicts the probability for a positive genetic test result (G+) in DCM/LVSD. Clinical, electrocardiogram, and echocardiographic variables were collected in 1,015 genotyped patients from Spain with DCM/LVSD. Multivariable logistic regression analysis was used to identify variables independently predicting G+, which were summed to create the Madrid Genotype Score. The external validation sample comprised 1,097 genotyped patients from the Maastricht and Trieste registries. A G+ result was found in 377 (37%) and 289 (26%) patients from the derivation and validation cohorts, respectively. Independent predictors of a G+ result in the derivation cohort were: family history of DCM (OR: 2.29; 95% CI: 1.73-3.04; P < 0.001), low electrocardiogram voltage in peripheral leads (OR: 3.61; 95% CI: 2.38-5.49; P < 0.001), skeletal myopathy (OR: 3.42; 95% CI: 1.60-7.31; P = 0.001), absence of hypertension (OR: 2.28; 95% CI: 1.67-3.13; P < 0.001), and absence of left bundle branch block (OR: 3.58; 95% CI: 2.57-5.01; P < 0.001). A score containing these factors predicted a G+ result, ranging from 3% when all predictors were absent to 79% when ≥4 predictors were present. Internal validation provided a C-statistic of 0.74 (95% CI: 0.71-0.77) and a calibration slope of 0.94 (95% CI: 0.80-1.10). The C-statistic in the external validation cohort was 0.74 (95% CI: 0.71-0.78). The Madrid Genotype Score is an accurate tool to predict a G+ result in DCM/LVSD. (J Am Coll Cardiol 2022;80:1115-1126) © 2022 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Late gadolinium enhancement distribution patterns in non-ischaemic dilated cardiomyopathy, genotype-phenotype correlation

  • De Frutos, Fernando|||0000-0003-4350-3217
  • Ochoa, Juan Pablo|||0000-0002-7966-0313
  • Fernández, Ana Isabel|||0000-0002-1509-5191
  • Gallego-Delgado, María|||0000-0003-0726-9646
  • Navarro-Peñalver, Marina
  • Casas, Guillem|||0000-0001-7122-320X
  • Basurte-Elorz, María Teresa|||0000-0002-8689-0301
  • Larrañaga-Moreira, José María
  • Mogollón, María Victoria
  • Robles-Mezcua, Ainhoa
  • García-Granja, Pablo Elpidio|||0000-0002-0750-1567
  • Climent, Vicente|||0000-0001-7362-1922
  • Palomino-Doza, Julián
  • García-Álvarez, Ana|||0000-0002-1718-2424
  • Brion, María|||0000-0001-7463-2148
  • Brugada, Ramon|||0000-0001-6607-3032
  • Jiménez-Jáimez, Juan|||0000-0001-5541-898X
  • Bayés-Genís, Antoni|||0000-0002-3044-197X
  • Ripoll-Vera, Tomás|||0000-0001-9222-325X
  • Peña-Peña, María Luisa
  • Rodríguez Palomares, José F.|||0000-0002-7229-9780
  • Gonzalez-Carrillo, Josefa
  • Villacorta, Eduardo|||0000-0003-0486-1740
  • Espinosa, Maria Angeles
  • García-Pavía, Pablo|||0000-0002-5470-2257
  • Mirelis, Jesus G.
Late gadolinium enhancement (LGE) is frequently found in patients with dilated cardiomyopathy (DCM); there is little information about its frequency and distribution pattern according to the underlying genetic substrate. We sought to describe LGE patterns according to genotypes and to analyse the risk of major ventricular arrhythmias (MVA) according to patterns. Cardiac magnetic resonance findings and LGE distribution according to genetics were performed in a cohort of 600 DCM patients followed at 20 Spanish centres. After exclusion of individuals with multiple causative gene variants or with variants in infrequent DCM-causing genes, 577 patients (34% females, mean age 53.5 years, left ventricular ejection fraction 36.9 ± 13.9%) conformed to the final cohort. A causative genetic variant was identified in 219 (38%) patients, and 147 (25.5%) had LGE. Significant differences were found comparing LGE patterns between genes (P < 0.001). LGE was absent or rare in patients with variants in TNNT2, RBM20, and MYH7 (0, 5, and 20%, respectively). Patients with variants in DMD, DSP, and FLNC showed a predominance of LGE subepicardial patterns (50, 41, and 18%, respectively), whereas patients with variants in TTN, BAG3, LMNA, and MYBPC3 showed unspecific LGE patterns. The genetic yield differed according to LGE patterns. Patients with subepicardial, lineal midwall, transmural, and right ventricular insertion points or with combinations of LGE patterns showed an increased risk of MVA compared with patients without LGE. LGE patterns in DCM have a specific distribution according to the affected gene. Certain LGE patterns are associated with an increased risk of MVA and with an increased yield of genetic testing.